Interobserver agreement of [68Ga]Ga-PSMA-11 PET/CT images interpretation in men with newly diagnosed prostate cancer

Abstract Background Prostate-specific membrane antigen (PSMA) ligand PET/CT has already provided promising results in prostate cancer (PC) imaging, yet simple and reproductible reporting criteria are still lacking. This study aimed at retrospectively evaluating interobserver agreement of [68Ga]Ga-PS...

Full description

Bibliographic Details
Main Authors: Céline Derwael, Olivier Lavergne, Pierre Lovinfosse, Vlad Nechifor, Mallory Salvé, David Waltregny, Roland Hustinx, Nadia Withofs
Format: Article
Language:English
Published: SpringerOpen 2020-02-01
Series:EJNMMI Research
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13550-020-0596-4
_version_ 1818294366447337472
author Céline Derwael
Olivier Lavergne
Pierre Lovinfosse
Vlad Nechifor
Mallory Salvé
David Waltregny
Roland Hustinx
Nadia Withofs
author_facet Céline Derwael
Olivier Lavergne
Pierre Lovinfosse
Vlad Nechifor
Mallory Salvé
David Waltregny
Roland Hustinx
Nadia Withofs
author_sort Céline Derwael
collection DOAJ
description Abstract Background Prostate-specific membrane antigen (PSMA) ligand PET/CT has already provided promising results in prostate cancer (PC) imaging, yet simple and reproductible reporting criteria are still lacking. This study aimed at retrospectively evaluating interobserver agreement of [68Ga]Ga-PSMA-11 PET/CT images interpretation according to PC molecular imaging standardized evaluation (PROMISE) criteria and reproducibility of PSMA reporting and data systems (RADS). Methods Forty-three patients with newly diagnosed, histologically proven intermediate- or high-risk PC, eligible for radical prostatectomy and who underwent [68Ga]Ga-PSMA-11 PET/CT before surgery were retrospectively included. Three nuclear medicine physicians (2 experienced and 1 resident) independently reviewed PET/CT images. Interpretation of [68Ga]Ga-PSMA-11 PET/CT images was based on PROMISE criteria including miTNM staging and lesions miPSMA expression score visual estimation and PSMA-RADS version 1.0 for a given scan. Readers’ agreement was measured using Krippendorff’s coefficients Results Agreement between observers was almost perfect (coefficient ≥ 0.81) for miM; it was substantial (coefficient ≥ 0.61) for the following criteria: miT, miN, PSMA-RADS, and miPSMA expression score of primary PC lesion and metastases. However, agreement was moderate (coefficient = 0.41–0.60) for miPSMA score of positive lymph nodes and for detection of PC primary lesion. Conclusion Visual interpretation of [68Ga]Ga-PSMA-11 PET/CT images in patients with newly diagnosed PC in a clinical setting leads to at least substantial agreement for PROMISE criteria and PSMA-RADS classification except for PC primary lesion detection and for miPSMA expression scoring of positive lymph nodes that might have been hampered by the interindividual variability of reference organs PSMA expression.
first_indexed 2024-12-13T03:30:36Z
format Article
id doaj.art-28f7e107398e49b1aedb3dccd9dc3d61
institution Directory Open Access Journal
issn 2191-219X
language English
last_indexed 2024-12-13T03:30:36Z
publishDate 2020-02-01
publisher SpringerOpen
record_format Article
series EJNMMI Research
spelling doaj.art-28f7e107398e49b1aedb3dccd9dc3d612022-12-22T00:01:10ZengSpringerOpenEJNMMI Research2191-219X2020-02-0110111010.1186/s13550-020-0596-4Interobserver agreement of [68Ga]Ga-PSMA-11 PET/CT images interpretation in men with newly diagnosed prostate cancerCéline Derwael0Olivier Lavergne1Pierre Lovinfosse2Vlad Nechifor3Mallory Salvé4David Waltregny5Roland Hustinx6Nadia Withofs7Division of Nuclear Medicine and Oncological Imaging, Department of Medical Physics, CHU of LiegeDepartment of Urology, CHR of LiegeDivision of Nuclear Medicine and Oncological Imaging, Department of Medical Physics, CHU of LiegeDepartment of Urology, CHU of LiegeDivision of Nuclear Medicine and Oncological Imaging, Department of Medical Physics, CHU of LiegeDepartment of Urology, CHU of LiegeDivision of Nuclear Medicine and Oncological Imaging, Department of Medical Physics, CHU of LiegeDivision of Nuclear Medicine and Oncological Imaging, Department of Medical Physics, CHU of LiegeAbstract Background Prostate-specific membrane antigen (PSMA) ligand PET/CT has already provided promising results in prostate cancer (PC) imaging, yet simple and reproductible reporting criteria are still lacking. This study aimed at retrospectively evaluating interobserver agreement of [68Ga]Ga-PSMA-11 PET/CT images interpretation according to PC molecular imaging standardized evaluation (PROMISE) criteria and reproducibility of PSMA reporting and data systems (RADS). Methods Forty-three patients with newly diagnosed, histologically proven intermediate- or high-risk PC, eligible for radical prostatectomy and who underwent [68Ga]Ga-PSMA-11 PET/CT before surgery were retrospectively included. Three nuclear medicine physicians (2 experienced and 1 resident) independently reviewed PET/CT images. Interpretation of [68Ga]Ga-PSMA-11 PET/CT images was based on PROMISE criteria including miTNM staging and lesions miPSMA expression score visual estimation and PSMA-RADS version 1.0 for a given scan. Readers’ agreement was measured using Krippendorff’s coefficients Results Agreement between observers was almost perfect (coefficient ≥ 0.81) for miM; it was substantial (coefficient ≥ 0.61) for the following criteria: miT, miN, PSMA-RADS, and miPSMA expression score of primary PC lesion and metastases. However, agreement was moderate (coefficient = 0.41–0.60) for miPSMA score of positive lymph nodes and for detection of PC primary lesion. Conclusion Visual interpretation of [68Ga]Ga-PSMA-11 PET/CT images in patients with newly diagnosed PC in a clinical setting leads to at least substantial agreement for PROMISE criteria and PSMA-RADS classification except for PC primary lesion detection and for miPSMA expression scoring of positive lymph nodes that might have been hampered by the interindividual variability of reference organs PSMA expression.http://link.springer.com/article/10.1186/s13550-020-0596-4Interobserver agreementPSMA-RADSPROMISEmiTNMPSMA PETStandardized evaluation
spellingShingle Céline Derwael
Olivier Lavergne
Pierre Lovinfosse
Vlad Nechifor
Mallory Salvé
David Waltregny
Roland Hustinx
Nadia Withofs
Interobserver agreement of [68Ga]Ga-PSMA-11 PET/CT images interpretation in men with newly diagnosed prostate cancer
EJNMMI Research
Interobserver agreement
PSMA-RADS
PROMISE
miTNM
PSMA PET
Standardized evaluation
title Interobserver agreement of [68Ga]Ga-PSMA-11 PET/CT images interpretation in men with newly diagnosed prostate cancer
title_full Interobserver agreement of [68Ga]Ga-PSMA-11 PET/CT images interpretation in men with newly diagnosed prostate cancer
title_fullStr Interobserver agreement of [68Ga]Ga-PSMA-11 PET/CT images interpretation in men with newly diagnosed prostate cancer
title_full_unstemmed Interobserver agreement of [68Ga]Ga-PSMA-11 PET/CT images interpretation in men with newly diagnosed prostate cancer
title_short Interobserver agreement of [68Ga]Ga-PSMA-11 PET/CT images interpretation in men with newly diagnosed prostate cancer
title_sort interobserver agreement of 68ga ga psma 11 pet ct images interpretation in men with newly diagnosed prostate cancer
topic Interobserver agreement
PSMA-RADS
PROMISE
miTNM
PSMA PET
Standardized evaluation
url http://link.springer.com/article/10.1186/s13550-020-0596-4
work_keys_str_mv AT celinederwael interobserveragreementof68gagapsma11petctimagesinterpretationinmenwithnewlydiagnosedprostatecancer
AT olivierlavergne interobserveragreementof68gagapsma11petctimagesinterpretationinmenwithnewlydiagnosedprostatecancer
AT pierrelovinfosse interobserveragreementof68gagapsma11petctimagesinterpretationinmenwithnewlydiagnosedprostatecancer
AT vladnechifor interobserveragreementof68gagapsma11petctimagesinterpretationinmenwithnewlydiagnosedprostatecancer
AT mallorysalve interobserveragreementof68gagapsma11petctimagesinterpretationinmenwithnewlydiagnosedprostatecancer
AT davidwaltregny interobserveragreementof68gagapsma11petctimagesinterpretationinmenwithnewlydiagnosedprostatecancer
AT rolandhustinx interobserveragreementof68gagapsma11petctimagesinterpretationinmenwithnewlydiagnosedprostatecancer
AT nadiawithofs interobserveragreementof68gagapsma11petctimagesinterpretationinmenwithnewlydiagnosedprostatecancer